Antimicrobial Studies of N-Heterocyclic Carbene Silver Complexes Containing Benzimidazol-2-ylidene Ligand | Zendy

Yetkın Gök | Zendy; Yakup Sarı | Zendy; Senem Akkoç | Zendy; İlknur Özdemır | Zendy; Selamı Günal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antimicrobial Studies of N-Heterocyclic Carbene Silver Complexes Containing Benzimidazol-2-ylidene Ligand

Author(s) -

Yetkın Gök,

Yakup Sarı,

Senem Akkoç,

İlknur Özdemır,

Selamı Günal

Publication year - 2014

Publication title -

international journal of inorganic chemistry

Language(s) - English

Resource type - Journals

eISSN - 2090-2026

pISSN - 2090-2034

DOI - 10.1155/2014/191054

Subject(s) - carbene , antimicrobial , candida albicans , pseudomonas aeruginosa , chemistry , candida tropicalis , enterococcus faecalis , dichloromethane , escherichia coli , microbiology and biotechnology , staphylococcus aureus , ligand (biochemistry) , agar dilution , agar , corpus albicans , silver nitrate , bacteria , nuclear chemistry , organic chemistry , biology , minimum inhibitory concentration , catalysis , biochemistry , genetics , receptor , solvent , gene

Seven novel 4-vinylbenzyl substituted N-heterocyclic carbene (NHC) silver complexes were synthesized from different benzimidazolium salts and silver (I) oxide in dichloromethane at room temperature. These new 4-vinylbenzyl substituted NHC silver complexes were characterized by spectroscopic (NMR, IR) and elemental analysis techniques. Using the agar dilution procedure, the antimicrobial activities of these synthesized new compounds were investigated against Gram (+)/(−) bacterial and fungal strains. These NHC silver complexes showed effective activities against Escherichia coli, Pseudomonas aeruginosa (Gram-negative bacterial strains), Enterococcus faecalis, Staphylococcus aureus (Gram-positive bacterial strains), and Candida tropicalis and Candida albicans (fungal strains)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research